Oculodentodigital Dysplasia: A Hypomyelinating Leukodystrophy with a Characteristic MRI Pattern of Brain Stem Involvement

I. Harting; S. Karch; U. Moog; A. Seitz; P.J.W. Pouwels; N.I. Wolf

doi:10.3174/ajnr.A6051

Abstract

SUMMARY: Oculodentodigital dysplasia, a rare genetic disorder caused by mutations in the gene encoding gap junction protein 1, classically presents with typical facial features, dental and ocular anomalies, and syndactyly. Oligosymptomatic patients are common and difficult to recognize, in particular if syndactyly is absent. Neurologic manifestation occurs in approximately 30% of patients, and leukodystrophy or T2 hypointensity of gray matter structures or both have been noted in individual patients. To investigate MR imaging changes in oculodentodigital dysplasia, we retrospectively and systematically reviewed 12 MRIs from 6 genetically confirmed patients. Diffuse supratentorial hypomyelination, T2-hypointense Rolandic and primary visual cortex, and symmetric involvement of middle cerebellar peduncle, pyramidal tract, and medial lemniscus was present in all, T2-hypointense pallidum and dentate nucleus in 2 patients each. This consistent, characteristic pattern of diffuse supratentorial hypomyelination and brain stem involvement differs from other hypomyelinating and nonhypomyelinating leukodystrophies with brain stem involvement, and its recognition should trigger genetic testing for oculodentodigital dysplasia.

ABBREVIATIONS:

NAWM: normal appearing white matter
ODDD: oculodentodigital dysplasia

Oculodentodigital dysplasia (ODDD) is a rare genetic disorder caused by mutations in the gene encoding gap junction protein 1, also called Connexin 43 (GJA1; Online Mendelian Inheritance in Man Nos. 164200 and 257850). Patients show typical facial features including a narrow nose, hypoplastic alae nasi, short palpebral fissures, and epicanthal folds (92% of patients). Ocular, in particular anterior chamber, anomalies, and dental involvement, namely microdontia and enamel hypoplasia (approximately 70%), as well as syndactyly of fourth and fifth finger (in 80%) are common.¹ Neurologic manifestations occur in approximately 30% of patients, including spastic paraparesis, prominent urinary incontinence, ataxia, dysarthria, seizures, and, infrequently, developmental delay or mild intellectual disability.^1,2

Beighton et al³ first reported CT with calcification of the basal ganglia in patients with ODDD in 1979. T2 hypointensity of deep gray matter structures and supratentorial cortical regions (eg, the central region) was subsequently reported for individual patients examined with MR imaging. Diffuse T2 hyperintensity of supratentorial white matter has been observed in individual cases, brainstem involvement in three.^4⇓–6 Having noted brain stem involvement in our patients, we retrospectively reviewed cranial MR imaging, including ¹H-MR spectroscopy and DWI, of 6 genetically confirmed patients with MR imaging seen at our institutions to investigate the pattern of MR imaging changes in ODDD.

Materials and Methods

We retrospectively identified 6 patients with ODDD from 4 families with previous MR imaging who were diagnosed and/or followed at University Hospital Heidelberg and VU University Medical Center and Amsterdam Neuroscience. Their 12 cranial MRI scans (age at examination, 5–52 years; mean/median, 25.9/18.7 years) were systematically reviewed in consensus by a neuroradiologist (I.H.) and pediatric neurologist (N.I.W.), each with >15 years of experience in assessing white matter diseases. The study was approved by Heidelberg University (S-760/2018). Axial T2WI and T1WI were available for all 12 MRI scans, and sagittal T1WI/T2WI and DWI with ADC, for at least 1 MRI per patient (11/12 and 9/12 MRIs, respectively). MR imaging was assessed for the extent of T2WI white matter changes (focal/diffuse), corresponding T1WI signal changes, and involvement of specific white matter structures, namely the corpus callosum, anterior and posterior limbs of the internal capsule, pyramidal tract, brain stem tracts, and cerebellar peduncles. The central region and primary visual cortex, pallidum, thalamus, substantia nigra, red nucleus, and dentate nucleus were visually compared with normal-appearing white matter (NAWM) and with contrast in age-matched controls.

Gradient-echo T2* and SWI, available for 4 patients (6 MRIs: patient 1 [last MRI], patient 2, patient 5, patient 6), were checked for T2* hypointensities due to calcifications and were compared with contrast in age-matched controls. DWI and ADC maps were inspected for areas of altered diffusion compared with surrounding NAWM or gray matter. Quantitative ¹H-MR spectroscopy of the supratentorial white matter was acquired in all patients (point-resolved spectroscopy sequence or STEAM localization, TE = 20–35 ms). Metabolite values were quantified using LCModel (http://www.lcmodel.com/),⁷ compared with control values for each scanner,^8⇓–10 and graded as normal (within the mean ± 1 SD of controls), high/low-to-normal (differing by 1–2 SDs from the mean of controls), and high/low (above/below the mean ± 2 SDs).

Patients

Diagnosis was confirmed by mutation analysis of GJA1 in all patients; genetic and MR imaging findings are summarized in On-line Table 1.

Patient 1 had had correction of bilateral syndactyly of D IV and V at 9 months and was evaluated for action and intention tremor at 4 years of age. He also showed myopia, astigmatism, and hypodontia. His father (patient 5), older sister, paternal uncle, and grandmother (no MRIs) also had syndactyly of D IV and V partly in association with ocular and dental findings. Patients 2 and 6, adolescent daughter and mother, had bilateral syndactyly corrected in childhood; spastic paraparesis and urinary incontinence had developed in the mother in her mid-30s.^11,12 Patient 3 had mild motor delay. At 6 years of age, neurogenic bladder was diagnosed with secondary incontinence and frequent bouts of cystitis. Neurologic examination revealed mild spasticity and posterior column signs. Patient 4 had syndactyly of D IV and V of her right hand. She had normal motor milestones but was always clumsy. Motor symptoms became more prominent around 40 years of age with mild spastic paraparesis, ataxia, and posterior column signs on examination. She also developed neurogenic bladder. Optic discs were pale, pursuit movements saccadic.

MR Imaging

All patients had diffuse, mild T2 hyperintensity of the supratentorial white matter with normal T1 signal, characteristic of hypomyelination (Fig 1 and On-line Fig 1). Three patients had additional, focally more pronounced T2 hyperintensity with corresponding T1 hypointensity. The corpus callosum was involved in all patients, varying from T2 hyperintensity of the lateral splenium in the last MR imaging of patient 1 at 8.9 years of age to an entirely T2 hyperintense corpus callosum (patient 4). On sagittal images, the corpus callosum was thin in patients 2–6. The posterior limb of the internal capsule was T2 hyperintense in all patients and MRIs, while the anterior limb was normal in the youngest 2 and was involved to a varying extent in the older 4 patients. The younger 3 patients imaged within the first 2 decades had some subcortical NAWM, while this was scarce (patient 5) or absent (patients 4 and 6) in the older patients imaged at 41–52 years of age (On-line Fig 1).

Fig 1.

MR imaging pattern of ODDD. Mild, diffuse T2 hyperintensity of the supratentorial white matter (B–D) and normal T1 signal (E) characteristic of hypomyelination in patient 1 with involvement of the posterior limb of the internal capsule (B), lateral splenium (C), and typical brain stem tract involvement at the level of the pons (A). Note T2 hypointensity of the Rolandic cortex compared with subcortical NAWM (arrows) of the medial and superior frontal gyri (B–D) and of the primary visual cortex compared with the anterior limb of the internal capsule, genu, and subcortical frontal NAWM (B and C). The craniocervical junction is normal (F). For an overview of MR imaging changes of all patients see On-line Fig 1.

Infratentorially, all patients had T2 hyperintensity of the pontine pyramidal tract, medial lemniscus, raphe, and middle cerebellar peduncles, as well as a small, triangular T2 hyperintensity in the lateral pons with its base at the anterolateral pons, located medial to the entry zone, and an intraparenchymal course of the trigeminal nerve, consistent with the anterolateral portion of the middle cerebellar peduncle within the pons. T2 hyperintensity resulted in a typical pattern of signal changes at the level of the pons (Fig 2). In the youngest patient, the pontine pyramidal tract only became clearly T2 hyperintense at 7.5 years of age; in patients 3 and 4, the T2 hyperintensity extended into the pyramis. Inconsistently involved infratentorial white matter structures were the inferior cerebellar peduncle, superior cerebellar peduncle, and decussation of superior cerebellar peduncles (n = 2, 1, and 1, respectively; On-line Fig 2).

Fig 2.

Pattern of brain stem tract involvement. T2WI at the level of the pons demonstrates characteristic involvement of the pyramidal tract (1), lemniscus medialis (2, black arrow), raphe pontis (3, black arrow), middle cerebellar peduncle (4), and the triangular lateral pontine T2 hyperintensity consistent with the anterior course of the pontocerebellar fibers forming the middle cerebellar peduncle (5); schematic representation of tracts is given in inset in A 2, 3 in black. A, Patient 1, B, patient 2, C, patient 3, D, patient 4, E, patient 5, F, patient 6. Field strength is 3T in patient 3; otherwise, it is 1.5T. Images are from the last scan from patients with multiple scans.

The Rolandic and primary visual cortices appeared abnormally T2 hypointense, in patient 1 with hypo- instead of hyperintensity to NAWM visible in the same slice (Fig 1B, D) but without corresponding T2* hypointensity in the 4 patients with T2*/SWI. Due to white matter hyperintensity, the deep gray matter generally appeared relatively T2 hypointense. Compared with age-matched controls, however, only the pallidum (patients 2 and 6) and dentate nucleus (patients 3 and 5) were more T2 hypointense in 2 patients each, the pallidum with corresponding T2* hypointensity in both, T1 hyperintensity in patient 2 (On-line Fig 2), and the dentate without corresponding hypointensity in patient 5 with T2*WI.

DWI did not reveal areas of restricted diffusion. Although in some patients, the ADC was slightly increased in affected white matter areas, this was not very prominent. The craniocervical junction was depicted on sagittal images at least once in all patients, without evidence of stenosis or compression of the medulla.

White matter ¹H-MR spectroscopy findings were normal in patient 3. In the other 5 patients, Cr was high or high-to-normal; mIns was high, high-to-normal, or normal; NAA was normal or low-to-normal; and Cho was normal, low-to-normal, or low. These findings resulted in low or low-to-normal metabolite ratios of Cho/Cr and NAA/Cr, consistent with hypomyelination (On-line Table 2). Lactate was not detected, and thus was normal.

Discussion

While syndactyly in combination with typical facial features suggests ODDD, oligosymptomatic patients are common and – in particular if syndactyly is absent – difficult to recognize. Usually only patients with neurologic presentation, occurring in approximately 30%, will be referred for cranial MR imaging. In individual patients with MR imaging previously reported, white matter changes have commonly been observed,^{2,4⇓–6,13⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–25} including brain stem involvement in 3^4⇓–6 and, less commonly, T2 hypointensity of cortical or deep gray matter structures.^{2,5,6,14⇓–16,22,23} As yet, there are no histopathologic data.

The pattern of brain structures involved in leukodystrophies has been shown to be highly specific and effective for a differential diagnosis using a practical diagnostic algorithm, with differentiation between hypomyelinating and nonhypomyelinating leukodystrophies as the first discriminator.²⁶ Hypomyelination is characterized by moderate T2 hyperintensity, less bright than in nonhypomyelinating leukodystrophies, eg, demyelination or vacuolation. T1 signal depends on the amount of myelin deposited and is often normal or otherwise iso- or mildly hypointense.^26,27 On ¹H-MR spectroscopy, elevated Cr and mIns in combination with normal or near-normal NAA, low (-normal) NAA/Cr, and low (-normal) Cho are typical.^8,9

In all MRIs of our patients, supratentorial white matter changes were characteristic of hypomyelination and accompanied by typical ¹H-MR spectroscopy findings in 5 of 6. Three patients imaged during late adolescence and adulthood had foci of more pronounced white matter changes consistent with small areas of secondary degeneration with loss of myelin and astrogliosis. Scarce or absent subcortical NAWM and involvement of the anterior limb of internal capsule only in the 3 oldest patients suggest progression of white matter changes with time as does extension of pyramidal tract hyperintensity from the mesencephalon to the pons during follow-up in the youngest patient.

Hypomyelinating leukodystrophies can be differentiated on the basis of additional, characteristic MR findings, eg, as in hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC) or by the presence of non-neurological features, e.g. congenital cataract in hypomyelination with congenital cataract (HCC), hypodontia and/or delayed puberty in 4H syndrome, or syndactyly in ODDD.²⁷ However, systemic manifestations are not obligatory and therefore may not be present in all patients, as seen in patient 3 who presented with mild spasticity, sensory deficit, and neurogenic bladder but without syndactyly. Even within families, signs and symptoms may vary.¹ Notably, all our patients, irrespective of the presence or absence of neurologic manifestation or syndactyly, had a characteristic pattern of brain stem tract involvement in addition to supratentorial hypomyelination, which differed from other hypomyelinating leukodystrophies with brain stem involvement. In Pelizaeus-Merzbacher-like disease, there is prominent T2 hyperintensity of the basis pontis, not always restricted to the pyramidal tract²⁸; in 4H syndrome the medial lemniscus is relatively spared²⁹; in hypomyelination of early myelinating structures³⁰ the medulla oblongata and caudal pons are more extensively involved than in ODDD; moreover, none of these disorders involve the middle cerebellar peduncles. Whereas hypomyelination with brain stem and spinal cord involvement and leg spasticity³¹ involves the medial lemniscus and pyramidal tract similar to ODDD, the inferior and superior but not middle cerebellar peduncles are T2 hyperintense.

When using prominent brain stem involvement as a starting point of an MR imaging–based differential diagnosis, ODDD must also be differentiated from 3 nonhypomyelinating leukodystrophies: Brain stem involvement is similar in autosomal dominant leukodystrophy related to duplication of the lamin B1 gene,³² but supratentorial white matter changes are more T2 hyperintense, not consistent with hypomyelination, and tend to spare a periventricular rim. T2 hyperintensity of the middle cerebellar peduncles in fragile X premutation carriers is combined with T2 hyperintensity of the deep cerebellar white matter, while the medial lemniscus and pyramidal tract are not affected.³³ Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation³⁴ involves the medial lemniscus and pyramidal tract, inferior and superior, but not the middle cerebellar peduncle and again differs by much more prominent supratentorial T2 hyperintensity not consistent with hypomyelination.

It has previously been noted that patients with ODDD imaged in the first decade may have MR imaging changes despite the absence of neurologic symptoms.¹ Similarly, all 6 patients had extensive pyramidal tract involvement and involvement of the medial lemniscus on MR imaging, irrespective of the presence of spasticity or impaired sensibility. Compression of the medulla at the craniocervical junction, as initially suggested due to a hyperostotic skull base,³ was not confirmed on MR imaging, either in later reports or in our patients.

Earlier reports also noted calcifications of the basal ganglia, which are a likely correlate of the T2 hypointensity reported in the literature^{5,6,14⇓–16,23} and of pallidal T2/T2* hypointensity in patients 2 and 6, though we cannot exclude abnormal iron accumulation as previously suggested.⁶ Consistent with previous reports, the Rolandic and primary visual cortices appeared abnormally T2 hypointense, however without corresponding T2* hypointensity and, therefore, not suggestive of either calcification or abnormal brain iron accumulation.

Conclusions

Brain imaging in 6 patients from 4 families with genetically confirmed ODDD shows a characteristic MR imaging pattern of brain stem tract involvement, consisting of the middle cerebellar peduncle, pyramidal tract, and medial lemniscus in combination with diffuse, supratentorial hypomyelination. Recognition of this pattern should trigger genetic evaluation of undiagnosed patients and thereby shorten the diagnostic process.

REFERENCES

1.↵
2. Paznekas W,
3. Karczeski B,
4. Vermeer S, et al
. GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 2009;30:724–33 doi:10.1002/humu.20958 pmid:19338053
CrossRef PubMed
2.↵
2. Loddenkemper T,
3. Grote K,
4. Evers S, et al
. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol 2002;249:584–95 doi:10.1007/s004150200068 pmid:12021949
CrossRef PubMed
3.↵
2. Beighton P,
3. Hamersma H,
4. Raad M
. Oculodento-osseous dysplasia: heterogeneity or variable expression? Clin Genet 1979;16:169–77 pmid:226298
PubMed
4.↵
2. Park KW,
3. Ryu HS,
4. Kim J, et al
. Oculodentodigital dysplasia presenting as spastic paraparesis: the first genetically confirmed Korean case and a literature review. J Mov Disord 2017;10:149–53 doi:10.14802/jmd.17050 pmid:28950687
CrossRef PubMed
5.↵
2. Furuta N,
3. Ikeda N,
4. Hirayanagi K, et al
. Novel GJA1 mutation in oculodentodigital dysplasia with progressive spastic paraplegia and sensory deficits. Intern Med 2012;51:93–98 doi:10.2169/internalmedicine.51.5770 pmid:22214631
CrossRef PubMed
6.↵
2. Gutmann DH,
3. Zackai EH,
4. McDonald-McGinn DM, et al
. Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter. Am J Med Genet 1991;41:18–20 doi:10.1002/ajmg.1320410106 pmid:1659191
CrossRef PubMed
7.↵
2. Provencher S
. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79 doi:10.1002/mrm.1910300604 pmid:8139448
CrossRef PubMed
8.↵
2. van der Voorn JP,
3. Pouwels PJ,
4. Hart AA, et al
. Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006;241:510–17 doi:10.1148/radiol.2412051345 pmid:17057071
CrossRef PubMed
9.↵
2. Steenweg ME,
3. Wolf NI,
4. van Wieringen WN, et al
. Quantitative MRI in hypomyelinating disorders: correlation with motor handicap. Neurology 2016;87:752–58 doi:10.1212/WNL.0000000000003000 pmid:27440150
CrossRef PubMed
10.↵
2. Harting I,
3. Boy N,
4. Heringer J, et al
. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites. J Inherit Metab Dis 2015;38:829–38 doi:10.1007/s10545-015-9826-8 pmid:25860816
CrossRef PubMed
11.↵
2. Thomsen M,
3. Schneider U,
4. Weber M, et al
. The different appearance of the oculodentodigital dysplasia syndrome. J Pediatr Orthop B 1998;7:23–26 pmid:9481652
PubMed
12.↵
2. Wiest T,
3. Herrmann O,
4. Stögbauer F, et al
. Clinical and genetic variability of oculodentodigital dysplasia. Clin Genet 2006;70:71–72 doi:10.1111/j.1399-0004.2006.00631.x pmid:16813608
CrossRef PubMed
13.↵
2. Alao MJ,
3. Bonneau D,
4. Holder-Espinasse M, et al
. Oculo-dento-digital dysplasia: lack of genotype–phenotype correlation for GJA1 mutations and usefulness of neuro-imaging. Eur J Med Genet 2010;53:19–22 doi:10.1016/j.ejmg.2009.08.007 pmid:19808103
CrossRef PubMed
14.↵
2. Ganos C,
3. Münchau A,
4. Holst B, et al
. Teaching neuroimages: oculodentodigital dysplasia. Neurology 2012;79:e140 doi:10.1212/WNL.0b013e31826e9b51 pmid:23071171
FREE Full Text
15.↵
2. Barzegar M,
3. Sayadnasiri M,
4. Tabrizi A
. Epilepsy as a rare neurologic manifestation of oculodentodigitalis dysplasia. Iran J Child Neurol 2012;6:39–43 pmid:24665271
PubMed
16.↵
2. Ginsberg LE,
3. Jewett T,
4. Grub R, et al
. Oculodental digital dysplasia: neuroimaging in a kindred. Neuroradiology 1996;38:84–86 doi:10.1007/BF00593230 pmid:8773286
CrossRef PubMed
17.↵
2. Jamsheer A,
3. Badura-Stronka M,
4. Sowińska A, et al
. A severe progressive oculodentodigital dysplasia due to compound heterozygous GJA1 mutation. Clin Genet 2010;78:94–97 doi:10.1111/j.1399-0004.2010.01412.x pmid:20597923
CrossRef PubMed
18.↵
2. Norton K,
3. Carey J,
4. Gutmann D
. Oculodentodigital dysplasia with cerebral white matter abnormalities in a two-generation family. Am J Med Genet 1995;57:458–61 doi:10.1002/ajmg.1320570320 pmid:7677152
CrossRef PubMed
19.↵
2. Shapiro R,
3. Griffin J,
4. Stine O
. Evidence for genetic anticipation in the oculodentodigital syndrome. Am J Med Genet 1997;71:36–41 doi:10.1002/(SICI)1096-8628(19970711)71:1<36::AID-AJMG7≫3.0.CO;2-O pmid:9215766
CrossRef PubMed
20.↵
2. Stanislaw CL,
3. Narvaez C,
4. Rogers RG, et al
. Oculodentodigital dysplasia with cerebral white matter abnormalities: an additional case. Proc Greenwood Genet Center 1998;17:20–24
21.↵
2. van Es RJ,
3. Wittebol-Post D,
4. Beemer FA
. Oculodentodigital dysplasia with mandibular retrognathism and absence of syndactyly: a case report with a novel mutation in the connexin 43 gene. Int J Oral Maxillofac Surg 2007;36:858–60 doi:10.1016/j.ijom.2007.03.004 pmid:17509830
CrossRef PubMed
22.↵
2. Amador C,
3. Mathews AM,
4. Del Carmen Montoya M, et al
. Expanding the neurologic phenotype of oculodentodigital dysplasia in a 4-generation Hispanic family. J Child Neurol 2008;23:901–05 doi:10.1177/0883073808317730 pmid:18660473
CrossRef PubMed
23.↵
2. Schrander-Stumpel C,
3. Franke C
. Central nervous system abnormalities in oculodentodigital dysplasia. Genet Counsel 1996;7:233–35 pmid:8897047
PubMed
24.↵
2. Kogame T,
3. Dainichi T,
4. Shimomura Y, et al
. Palmoplantar keratosis in oculodentodigital dysplasia with a GJA1 point mutation out of the C-terminal region of connexin 43. J Dermatol 2014;41:1095–97 doi:10.1111/1346-8138.12682 pmid:25388818
CrossRef PubMed
25.↵
2. Tumminelli G,
3. Di Donato I,
4. Guida V, et al
. Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene. J Alzheimers Dis 2016;49:27–30 doi:10.3233/JAD-150424 pmid:26444782
CrossRef PubMed
26.↵
2. Schiffmann R,
3. van der Knaap M
. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009;72:750–59 doi:10.1212/01.wnl.0000343049.00540.c8 pmid:19237705
Abstract/FREE Full Text
27.↵
2. Pouwels PJ,
3. Vanderver A,
4. Bernard G, et al
. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol 2014;76:5–19 doi:10.1002/ana.24194 pmid:24916848
CrossRef PubMed
28.↵
2. Biancheri R,
3. Rosano C,
4. Denegri L, et al
. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur J Hum Genet 2013;21:34–39 doi:10.1038/ejhg.2012.93 pmid:22669416
CrossRef PubMed
29.↵
2. Cayami FK,
3. Bugiani M,
4. Pouwels PJ, et al
. 4H leukodystrophy: lessons from 3T imaging. Neuropediatrics 2018;49:112–17 doi:10.1055/s-0037-1608780 pmid:29179231
CrossRef PubMed
30.↵
2. Steenweg ME,
3. Wolf NI,
4. Schieving JH, et al
. Novel hypomyelinating leukoencephalopathy affecting early myelinating structures. Arch Neurol 2012;69:125–28 doi:10.1001/archneurol.2011.1030 pmid:22232354
CrossRef PubMed
31.↵
2. Taft RJ,
3. Vanderver A,
4. Leventer RJ, et al
. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet 2013;92:774–80 doi:10.1016/j.ajhg.2013.04.006 pmid:23643384
CrossRef PubMed
32.↵
2. Dos Santos MM,
3. Grond-Ginsbach C,
4. Aksay SS, et al
. Adult-onset autosomal dominant leukodystrophy due to LMNB1 gene duplication. J Neurol 2012;259:579–81 doi:10.1007/s00415-011-6225-4 pmid:21909802
CrossRef PubMed
33.↵
2. Brunberg JA,
3. Jacquemont S,
4. Hagerman RJ, et al
. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol 2002;23:1757–66 pmid:12427636
Abstract/FREE Full Text
34.↵
2. Scheper GC,
3. van der Klok T,
4. van Andel RJ, et al
. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534–39 doi:10.1038/ng2013 pmid:17384640
CrossRef PubMed

Received December 7, 2018.
Accepted after revision March 12, 2019.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Purchase

Cited By...

More in this TOC Section

Show more PEDIATRICS

[1] 1.↵

Paznekas W,
Karczeski B,
Vermeer S, et al
. GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 2009;30:724–33 doi:10.1002/humu.20958 pmid:19338053
CrossRef PubMed

[3] Paznekas W,

[4] Karczeski B,

[5] Vermeer S, et al

[6] 2.↵

Loddenkemper T,
Grote K,
Evers S, et al
. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol 2002;249:584–95 doi:10.1007/s004150200068 pmid:12021949
CrossRef PubMed

[8] Loddenkemper T,

[9] Grote K,

[10] Evers S, et al

[11] 3.↵

Beighton P,
Hamersma H,
Raad M
. Oculodento-osseous dysplasia: heterogeneity or variable expression? Clin Genet 1979;16:169–77 pmid:226298
PubMed

[13] Beighton P,

[14] Hamersma H,

[15] Raad M

[16] 4.↵

Park KW,
Ryu HS,
Kim J, et al
. Oculodentodigital dysplasia presenting as spastic paraparesis: the first genetically confirmed Korean case and a literature review. J Mov Disord 2017;10:149–53 doi:10.14802/jmd.17050 pmid:28950687
CrossRef PubMed

[18] Park KW,

[19] Ryu HS,

[20] Kim J, et al

[21] 5.↵

Furuta N,
Ikeda N,
Hirayanagi K, et al
. Novel GJA1 mutation in oculodentodigital dysplasia with progressive spastic paraplegia and sensory deficits. Intern Med 2012;51:93–98 doi:10.2169/internalmedicine.51.5770 pmid:22214631
CrossRef PubMed

[23] Furuta N,

[24] Ikeda N,

[25] Hirayanagi K, et al

[26] 6.↵

Gutmann DH,
Zackai EH,
McDonald-McGinn DM, et al
. Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter. Am J Med Genet 1991;41:18–20 doi:10.1002/ajmg.1320410106 pmid:1659191
CrossRef PubMed

[28] Gutmann DH,

[29] Zackai EH,

[30] McDonald-McGinn DM, et al

[31] 7.↵

Provencher S
. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79 doi:10.1002/mrm.1910300604 pmid:8139448
CrossRef PubMed

[33] Provencher S

[34] 8.↵

van der Voorn JP,
Pouwels PJ,
Hart AA, et al
. Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006;241:510–17 doi:10.1148/radiol.2412051345 pmid:17057071
CrossRef PubMed

[36] van der Voorn JP,

[37] Pouwels PJ,

[38] Hart AA, et al

[39] 9.↵

Steenweg ME,
Wolf NI,
van Wieringen WN, et al
. Quantitative MRI in hypomyelinating disorders: correlation with motor handicap. Neurology 2016;87:752–58 doi:10.1212/WNL.0000000000003000 pmid:27440150
CrossRef PubMed

[41] Steenweg ME,

[42] Wolf NI,

[43] van Wieringen WN, et al

[44] 10.↵

Harting I,
Boy N,
Heringer J, et al
. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites. J Inherit Metab Dis 2015;38:829–38 doi:10.1007/s10545-015-9826-8 pmid:25860816
CrossRef PubMed

[46] Harting I,

[47] Boy N,

[48] Heringer J, et al

[49] 11.↵

Thomsen M,
Schneider U,
Weber M, et al
. The different appearance of the oculodentodigital dysplasia syndrome. J Pediatr Orthop B 1998;7:23–26 pmid:9481652
PubMed

[51] Thomsen M,

[52] Schneider U,

[53] Weber M, et al

[54] 12.↵

Wiest T,
Herrmann O,
Stögbauer F, et al
. Clinical and genetic variability of oculodentodigital dysplasia. Clin Genet 2006;70:71–72 doi:10.1111/j.1399-0004.2006.00631.x pmid:16813608
CrossRef PubMed

[56] Wiest T,

[57] Herrmann O,

[58] Stögbauer F, et al

[59] 13.↵

Alao MJ,
Bonneau D,
Holder-Espinasse M, et al
. Oculo-dento-digital dysplasia: lack of genotype–phenotype correlation for GJA1 mutations and usefulness of neuro-imaging. Eur J Med Genet 2010;53:19–22 doi:10.1016/j.ejmg.2009.08.007 pmid:19808103
CrossRef PubMed

[61] Alao MJ,

[62] Bonneau D,

[63] Holder-Espinasse M, et al

[64] 14.↵

Ganos C,
Münchau A,
Holst B, et al
. Teaching neuroimages: oculodentodigital dysplasia. Neurology 2012;79:e140 doi:10.1212/WNL.0b013e31826e9b51 pmid:23071171
FREE Full Text

[66] Ganos C,

[67] Münchau A,

[68] Holst B, et al

[69] 15.↵

Barzegar M,
Sayadnasiri M,
Tabrizi A
. Epilepsy as a rare neurologic manifestation of oculodentodigitalis dysplasia. Iran J Child Neurol 2012;6:39–43 pmid:24665271
PubMed

[71] Barzegar M,

[72] Sayadnasiri M,

[73] Tabrizi A

[74] 16.↵

Ginsberg LE,
Jewett T,
Grub R, et al
. Oculodental digital dysplasia: neuroimaging in a kindred. Neuroradiology 1996;38:84–86 doi:10.1007/BF00593230 pmid:8773286
CrossRef PubMed

[76] Ginsberg LE,

[77] Jewett T,

[78] Grub R, et al

[79] 17.↵

Jamsheer A,
Badura-Stronka M,
Sowińska A, et al
. A severe progressive oculodentodigital dysplasia due to compound heterozygous GJA1 mutation. Clin Genet 2010;78:94–97 doi:10.1111/j.1399-0004.2010.01412.x pmid:20597923
CrossRef PubMed

[81] Jamsheer A,

[82] Badura-Stronka M,

[83] Sowińska A, et al

[84] 18.↵

Norton K,
Carey J,
Gutmann D
. Oculodentodigital dysplasia with cerebral white matter abnormalities in a two-generation family. Am J Med Genet 1995;57:458–61 doi:10.1002/ajmg.1320570320 pmid:7677152
CrossRef PubMed

[86] Norton K,

[87] Carey J,

[88] Gutmann D

[89] 19.↵

Shapiro R,
Griffin J,
Stine O
. Evidence for genetic anticipation in the oculodentodigital syndrome. Am J Med Genet 1997;71:36–41 doi:10.1002/(SICI)1096-8628(19970711)71:1<36::AID-AJMG7≫3.0.CO;2-O pmid:9215766
CrossRef PubMed

[91] Shapiro R,

[92] Griffin J,

[93] Stine O

[94] 20.↵

Stanislaw CL,
Narvaez C,
Rogers RG, et al
. Oculodentodigital dysplasia with cerebral white matter abnormalities: an additional case. Proc Greenwood Genet Center 1998;17:20–24

[96] Stanislaw CL,

[97] Narvaez C,

[98] Rogers RG, et al

[99] 21.↵

van Es RJ,
Wittebol-Post D,
Beemer FA
. Oculodentodigital dysplasia with mandibular retrognathism and absence of syndactyly: a case report with a novel mutation in the connexin 43 gene. Int J Oral Maxillofac Surg 2007;36:858–60 doi:10.1016/j.ijom.2007.03.004 pmid:17509830
CrossRef PubMed

[101] van Es RJ,

[102] Wittebol-Post D,

[103] Beemer FA

[104] 22.↵

Amador C,
Mathews AM,
Del Carmen Montoya M, et al
. Expanding the neurologic phenotype of oculodentodigital dysplasia in a 4-generation Hispanic family. J Child Neurol 2008;23:901–05 doi:10.1177/0883073808317730 pmid:18660473
CrossRef PubMed

[106] Amador C,

[107] Mathews AM,

[108] Del Carmen Montoya M, et al

[109] 23.↵

Schrander-Stumpel C,
Franke C
. Central nervous system abnormalities in oculodentodigital dysplasia. Genet Counsel 1996;7:233–35 pmid:8897047
PubMed

[111] Schrander-Stumpel C,

[112] Franke C

[113] 24.↵

Kogame T,
Dainichi T,
Shimomura Y, et al
. Palmoplantar keratosis in oculodentodigital dysplasia with a GJA1 point mutation out of the C-terminal region of connexin 43. J Dermatol 2014;41:1095–97 doi:10.1111/1346-8138.12682 pmid:25388818
CrossRef PubMed

[115] Kogame T,

[116] Dainichi T,

[117] Shimomura Y, et al

[118] 25.↵

Tumminelli G,
Di Donato I,
Guida V, et al
. Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene. J Alzheimers Dis 2016;49:27–30 doi:10.3233/JAD-150424 pmid:26444782
CrossRef PubMed

[120] Tumminelli G,

[121] Di Donato I,

[122] Guida V, et al

[123] 26.↵

Schiffmann R,
van der Knaap M
. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009;72:750–59 doi:10.1212/01.wnl.0000343049.00540.c8 pmid:19237705
Abstract/FREE Full Text

[125] Schiffmann R,

[126] van der Knaap M

[127] 27.↵

Pouwels PJ,
Vanderver A,
Bernard G, et al
. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol 2014;76:5–19 doi:10.1002/ana.24194 pmid:24916848
CrossRef PubMed

[129] Pouwels PJ,

[130] Vanderver A,

[131] Bernard G, et al

[132] 28.↵

Biancheri R,
Rosano C,
Denegri L, et al
. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur J Hum Genet 2013;21:34–39 doi:10.1038/ejhg.2012.93 pmid:22669416
CrossRef PubMed

[134] Biancheri R,

[135] Rosano C,

[136] Denegri L, et al

[137] 29.↵

Cayami FK,
Bugiani M,
Pouwels PJ, et al
. 4H leukodystrophy: lessons from 3T imaging. Neuropediatrics 2018;49:112–17 doi:10.1055/s-0037-1608780 pmid:29179231
CrossRef PubMed

[139] Cayami FK,

[140] Bugiani M,

[141] Pouwels PJ, et al

[142] 30.↵

Steenweg ME,
Wolf NI,
Schieving JH, et al
. Novel hypomyelinating leukoencephalopathy affecting early myelinating structures. Arch Neurol 2012;69:125–28 doi:10.1001/archneurol.2011.1030 pmid:22232354
CrossRef PubMed

[144] Steenweg ME,

[145] Wolf NI,

[146] Schieving JH, et al

[147] 31.↵

Taft RJ,
Vanderver A,
Leventer RJ, et al
. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet 2013;92:774–80 doi:10.1016/j.ajhg.2013.04.006 pmid:23643384
CrossRef PubMed

[149] Taft RJ,

[150] Vanderver A,

[151] Leventer RJ, et al

[152] 32.↵

Dos Santos MM,
Grond-Ginsbach C,
Aksay SS, et al
. Adult-onset autosomal dominant leukodystrophy due to LMNB1 gene duplication. J Neurol 2012;259:579–81 doi:10.1007/s00415-011-6225-4 pmid:21909802
CrossRef PubMed

[154] Dos Santos MM,

[155] Grond-Ginsbach C,

[156] Aksay SS, et al

[157] 33.↵

Brunberg JA,
Jacquemont S,
Hagerman RJ, et al
. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol 2002;23:1757–66 pmid:12427636
Abstract/FREE Full Text

[159] Brunberg JA,

[160] Jacquemont S,

[161] Hagerman RJ, et al

[162] 34.↵

Scheper GC,
van der Klok T,
van Andel RJ, et al
. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534–39 doi:10.1038/ng2013 pmid:17384640
CrossRef PubMed

[164] Scheper GC,

[165] van der Klok T,

[166] van Andel RJ, et al

Main menu

User menu

Search

American Journal of Neuroradiology

Oculodentodigital Dysplasia: A Hypomyelinating Leukodystrophy with a Characteristic MRI Pattern of Brain Stem Involvement

Abstract

ABBREVIATIONS: